March 2026 in “Revista Ibero-Americana de Humanidades, Ciências e Educação” This study reports that perioperative use of dutasteride, both orally and through mesotherapy, may enhance hair graft survival and reduce shock loss in patients undergoing hair transplantation for androgenetic alopecia.
January 2025 in “Editora Acadêmica Periodicojs eBooks” This review found that low-dose oral Minoxidil may be a viable alternative to topical Minoxidil for treating androgenetic alopecia, offering similar efficacy but with better adherence and different side effect profiles; consideration of patient-specific factors is important for treatment choice.
Low-dose oral minoxidil is effective and generally safe for treating hair loss in women.
January 2026 in “Magazine Portal Bibliotech Digital (Universidad Nacional de Colombia)” This study reviewed the literature on Minoxidil and finasteride for androgenetic alopecia, finding both drugs effective but noting potential side effects, with combined therapy possibly enhancing efficacy and patient adherence while reducing adverse effects.
December 2022 in “Zenodo (CERN European Organization for Nuclear Research)” In this integrative literature review, the researchers reported that finasteride appears highly effective for treating androgenetic alopecia and acne, showing notable benefits after brief treatment durations, though careful dose management is required due to potential sexual side effects.
